Finance

Lists
AORT:NYSE
Artivion Inc
$ 21.26
-1.62%
(-0.35) 1D
10-р сарын 8, 10:24:24 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AORT...
Open
$ 21.45
High
$ 21.45
Low
$ 21.17
Mkt. cap
1.04 тэрбум
Avg. vol.
602.53 мян
Volume
19.35 мян
52-wk high
$ 48.25
52-wk low
$ 19.16
EPS
-$ 0.07
Beta
1.23
Shares outstanding
48.76 сая
No. of employees
2 мян
Open
$ 21.45
High
$ 21.45
Low
$ 21.17
Mkt. cap
1.04 тэрбум
Avg. vol.
602.53 мян
Volume
19.35 мян
52-wk high
$ 48.25
52-wk low
$ 19.16
EPS
-$ 0.07
Beta
1.23
Shares outstanding
48.76 сая
No. of employees
2 мян
News stories
From web sources and news partners
Profile
Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive. Wikipedia
About Artivion Inc
CEOJames Patrick Mackin
Employees1.8 мян
Founded1984
HeadquartersKennesaw, Жоржиа, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to AORT in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AORT in the last 3 months.
Highest
Current $ 21.26
$ 45.00 (+111.67%)
Average
$ 41.87 (+96.94%)
Lowest
$ 38.00 (+78.74%)
Analyst
Recommendation
Action
Price target
Projected
Date
William Plovanic
Canaccord Genuity
Buy
Maintained
$ 40.00
+88.1%
08/18/2026
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Maintained
$ 39.20
+84.4%
08/07/2026
Frank Takkinen
Lake Street
Buy
Reiterated
$ 45.00
+111.7%
08/07/2026
Suraj Kalia
Oppenheimer
Buy
Reiterated
$ 38.00
+78.7%
08/07/2026
Rick Wise
Stifel Nicolaus
Buy
Reiterated
$ 45.00
+111.7%
08/07/2026
Michael Matson
Needham
Buy
Reiterated
$ 44.00
+107%
08/07/2026
Daniel Stauder
Citizens JMP
Buy
Maintained
$ 48.00
+125.8%
05/08/2026
Eric Martinuzzi
Lake Street
Buy
Reiterated
$ 55.00
+158.7%
04/08/2026
Last report
2026 оны 8-р сарын 6
Fiscal period
Q2 2026
EPS / Est. (USD)
$ 0.13 / $ 0.10
+34.48%beat
Revenue / Est. (USD)
125.76 сая / 120.01 сая
+4.79%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
113.39 сая
115.99 сая
116.34 сая
125.76 сая
Cost of goods sold
38.99 сая
42.85 сая
40.89 сая
45.24 сая
Cost of revenue
38.99 сая
42.85 сая
40.89 сая
45.24 сая
Research and development expenses
8.08 сая
9.12 сая
8.84 сая
9.06 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54.68 сая
54.64 сая
60.58 сая
60.13 сая
Operating expense
62.76 сая
63.76 сая
69.42 сая
69.18 сая
Total operating expenses
101.75 сая
106.61 сая
110.31 сая
114.42 сая
Operating income
11.64 сая
9.38 сая
6.03 сая
11.34 сая
Other non operating income
499.00 мян
1.18 сая
514.00 мян
-49.00 мян
EBT including unusual items
7.06 сая
6.54 сая
339.00 мян
-11.70 сая
EBT excluding unusual items
6.16 сая
5.15 сая
579.00 мян
3.70 сая
Income tax expense
554.00 мян
4.11 сая
-1.08 сая
1.81 сая
Effective tax rate
7.85%
62.89%
-317.99%
-15.48%
Other operating expenses
-
-
-
-
Net income
6.50 сая
2.43 сая
1.42 сая
-13.51 сая
Net profit margin
5.73%
2.09%
1.22%
-10.74%
Earnings per share
0.16
0.17
0.08
0.13
Interest and investment income
240.00 мян
311.00 мян
205.00 мян
367.00 мян
Interest expense
-6.12 сая
-5.62 сая
-5.37 сая
-7.25 сая
Net interest expenses
-5.88 сая
-5.31 сая
-5.16 сая
-6.89 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
17.35 сая
15.14 сая
12.37 сая
18.08 сая
Gain or loss from assets sale
-3.50 сая
-3.50 сая
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс